The impact of decentralised drug-budgets in Sweden - a survey of physicians' attitudes towards costs and cost-effectiveness

Health Policy

Volumn 76, Issue 3, 2006, Pages 299-311

  Jansson, Sandra ^a   Anell, Anders ^a  

^a SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

Author keywords

Attitudes; Cost awareness; Cost effectiveness; Drug budgets; Physicians; Prescribing

Indexed keywords

ARTICLE; COST; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DRUG SUBSTITUTION; HEALTH SURVEY; LOGISTIC REGRESSION ANALYSIS; MEDICAL SPECIALIST; PHYSICIAN; STATISTICAL ANALYSIS; STUDENT T TEST; SWEDEN;

BUDGETS; COST-BENEFIT ANALYSIS; DATA COLLECTION; DRUG COSTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIANS; POLITICS; STATE MEDICINE; SWEDEN;

EID: 33645954586     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2005.06.002     Document Type: Article

References (23)

1. Anell A, Jendteg S, Nordling S. Läkemedelsförskrivning och kostnadskontroll - vad kan Sverige lära av England, Tyskland och Holland? (Pharmaceutical prescribing and cost containment - what can Sweden learn from England, Germany and the Netherlands?). IHE Monograph. Lund: Rahms I Lund; 1999.
2. Harris C.M., and Scrivener G. Fundholders' prescribing costs: the first five years. British Medical Journal 313 (1996) 1531-1534
3. Swedish National Board of Health and Welfare (Socialstyrelsen). Läkemedelsreformen 1997 - hur blev det? (The Pharmaceutical Act of 1997 - how did it turn out?). Swedish National Board of Health and Welfare follows up and evaluates 2000:7. URL: http://www.socialstyrelsen.se/NR/rdonlyres/70426172-B4A3-4282-A6E7-5D925424C85A/1863/0015008.pdf.
4. Anell A, Nordling S. Decentraliserat kostnadsansvar för receptläkemedel - frågeställningar och erfarenheter från fem landsting (Decentralised prescription drug-budgets - questions and experiences from five county councils). Lund: IHE E-Report; 1999.
5. Nordling S, Anell A, Jansson S. Kostnadsansvar och belöningssystem för förbättrad läkemedelsanvändning. Kartläggning av landstingens förändringsarbete. (Decentralised drug-budgets and incentive schemes for improved drug utilisation. A survey among Swedish county councils). Lund: IHE Working Report no. 2003:1.
6. Denig P., and Haaijer-Ruskamp F.M. Do physicians take cost into account when making prescribing decisions?. Pharmacoeconomics 8 4 (1995) 282-289
7. Dillman D.A. Mail and telephone surveys. The total design method (1978), Wiley, New York
8. Mann P.S. Statistics for business and economics. Annotated instructor's edition (1995), John Wiley and Sons Inc., New York
9. Afifi A.A., and Clark V. Computer-aided multivariate analysis. 2nd ed. (1990), van Nostrand Reinhold, New York
10. Melander A, Nilsson LG. Läkares relationer till läkemedelskommittéer. Attityder och faktisk förskrivning (Physicianś relations to formulary committees. Attitudes and actual prescribing). NEPI - report. Stockholm: Apotekarsocieteten; 2001.
11. Mölstad S., Hovelius B., Kroon L., and Melander A. Prescription of antibiotics to out-patients in hospital clinics, community health centres and private practices. European Journal of Clinical Pharmacology 39 (1990) 9-12
12. Bijl D., Van Sonderen E., and Haaijer-Ruskamp F.M. Prescription changes and drug costs at the interface between primary and specialist care. European Journal of Clinical Pharmacology 54 (1998) 333-336
13. Håkansson A., Andersson H., Cars H., and Melander A. Prescribing, prescription costs and adherence to formulary committee recommendations: long-term differences between physicians in public and private care. European Journal of Clinical Pharmacology 57 (2001) 65-70
14. Ramel B. Dubbla lojaliteter - läkaretik i kläm när sötebrödsdagarna är slut (Double loyalties - medical ethics in jeopardy when the halcyon days are over). Läkartidningen 50 100 (2003) 4207-4209
15. Jan S. Why does economic analysis in health care not get implemented more? Towards a greater understanding of the rules of the game and the costs of decision-making. Applied Health Economics and Health Policy 1 (2003) 17-24
16. Ginsburg M.E., Kravitz R., and Sandberg W.A. A survey of physician attitudes and practices concerning cost-effectiveness in patient care. Western Journal of Medicine 173 (2000) 390-394
17. Forsberg E. Do financial incentives make a difference? A comparative study of the effects of performance-based reimbursement in Swedish health care. Doctoral thesis. Sweden: Faculty of Medicine at Uppsala University; 2001.
18. Hoffman C., Graf von der Schulenburg J.M., and on the behalf of the EUROMET group. The influence of economic evaluation studies on decision making. A European survey. Health Policy 52 (2000) 179-192
19. Arnesen T., and Fredriksen S. Coping with obligations towards patient and society: an empirical study of attitudes and practice among Norwegian physicians. Journal of Medical Ethics 21 (1995) 158-161
20. Crump B., Drummond M.F., Alexander S., and Devaney C. Economic evaluation in the United Kingdom National Health Service. In: Graf von der Schulenburg J.-M. (Ed). The Influences of economic evaluation studies on health care decision-making: a European survey (2000), I.O.S. Press, Amsterdam
21. Drummond M., Cooke J., and Walley T. Economic evaluation under managed competition: evidence from the UK. Social Science of Medicine 45 4 (1997) 583-595
22. Anell A., and Svarvar P. Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish Formulary Committees. Pharmacoeconomics 1782 (2000) 175-185
23. Hoffmann C., Stoykova B.A., Nixon J., Glanville J.M., Misso K., and Drummond M.F. Do health-care decision makers find economic evaluations useful? The findings of Focus Group Research in UK Health Authorities. Value in Health 5 2 (2002) 71-78